Will NASDAQ Delisting Stop BNB Price surge?
Is the BNB price surge over? Windtree Therapeutics (WINT) saw its shares plummet by 77% on Wednesday after the Nasdaq announced it would suspend trading of the stock due to not meeting the minimum bid requirements.
Windtree was recently in the announcement thanks to a BNB ▲2.19% treasury plan revealed in July. This strategy included a $60 million agreement with Build and Build Corp., along with options for an additional $140 million, marking it as one of the initial U.S.-listed firms to significantly invest in Binance’s native token.
The stock ended the day at $0.11, dropping over 99% year-to-date, as per Yahoo Finance.
The BNB Price Gamble Claims Another Casualty
Initially, shares surged over 30%, but the increase was short-lived. In just a few weeks, Windtree stock dropped by more than 90%, erasing nearly all crypto holder trust.
DISCOVER: 9+ Best High-Risk, High-Reward Crypto to Buy in August 2025
The company also revealed a $500 million equity line of credit with an undisclosed institutional trader, along with a $20 million deal with Build and Build Corp. for further BNB purchases. However, Windtree has not disclosed its current BNB holdings or if it intends to pursue this strategy after the Nasdaq delisting.
BNB TREASURY FIRM DROPS -77% AHEAD OF NASDAQ DELISTING
Windtree Therapeutics ( $WINT ) is set to be delisted from Nasdaq due to not maintaining a $1 minimum bid.
– The company adopted a $BNB treasury strategy in July, which included a $60M BNB acquisition and $500 million financing.
-… https://t.co/LT75hFJ2Of pic.twitter.com/ninqVKWug8
— Kapoor Kshitiz (@kshitizkapoor_) August 21, 2025
Windtree’s decline serves as a recent warning for companies betting on digital asset treasuries. Once marketed as a means to increase durability, this approach has left many firms heavily exposed to crypto market declines. Sharplink, which holds Ethereum assets, has recently reported significant losses facing similar challenges.
Data from DeFiLlama indicates the issue is wide-ranging: as crypto token values drop, stocks tied to treasuries experience similar declines. Windtree’s dependence on BNB assets resulted in its financial standing being adversely affected while investors were selling off its shares.
DISCOVER: Top 20 Crypto to Buy in 2025
With Windtree’s Fall, What Comes Next?
In a twist of irony, as Windtree faced suspension, BNB was achieving its own milestones, rising 5.6% to $876.26. The larger market had recovered from two-week lows, but those gains did not benefit Windtree’s financials.
This divide highlights a stark reality: companies linked to crypto assets don’t necessarily benefit alongside the tokens they hold if investors have lost confidence in their operational model.
Join The 99Bitcoins Announcement Discord Here For The Latest Market Updates
Key Takeaways
- Is the BNB bull run over? Windtree Therapeutics (WINT) shares fell 77% on Wednesday following Nasdaq’s update of stock suspension.
- Interestingly, as Windtree faced suspension, BNB was achieving its own highs, rallying by 5.6% to $876.26.
The post Will NASDAQ Delisting Kill BNB Price surge? was first published on 99Bitcoins.
